ArticleNeuro-oncology practice2019

Immunotherapy is associated with improved survival and decreased neurologic death after SRS for brain metastases from lung and melanoma primaries.

Claire M Lanier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.